Search research articles
Contact Us
Filters
Showing results (71-80 of 114) with videos related to
Page
of 12
Sort By:
Cancer
|
July 25, 2006
The effect of immunoglobulin VH gene mutation status and other prognostic factors on the incidence of major infections in patients with chronic lymphocytic leukemia
Sebastian Francis, Mamatha Karanth, Guy Pratt, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
December 18, 2008
The novel nuclear factor-kappaB inhibitor LC-1 is equipotent in poor prognostic subsets of chronic lymphocytic leukemia and shows strong synergy with fludarabine
Saman Hewamana, Thet Thet Lin, Chris Jenkins, et al.
Arrhythmia & Electrophysiology Review
|
October 28, 2022
UK Expert Consensus Statement for the Optimal Use and Clinical Utility of Leadless Pacing Systems on Behalf of the British Heart Rhythm Society
Paul R Roberts, Mohamed ElRefai, Paul Foley, et al.
Blood
|
June 12, 2010
Telomere dysfunction and fusion during the progression of chronic lymphocytic leukemia: evidence for a telomere crisis
Thet Thet Lin, Boitelo T Letsolo, Rhiannon E Jones, et al.
Oncotarget
|
February 6, 2014
A novel Cdk9 inhibitor preferentially targets tumor cells and synergizes with fludarabine
Elisabeth Walsby, Guy Pratt, Hao Shao, et al.
Communications Biology
|
July 29, 2022
DNA sequence-selective G-A cross-linking ADC payloads for use in solid tumour therapies
George Procopiou, Paul J M Jackson, Daniella di Mascio, et al.
European Journal of Medicinal Chemistry
|
February 13, 2021
Structure-based design of highly selective 2,4,5-trisubstituted pyrimidine CDK9 inhibitors as anti-cancer agents
Hao Shao, David W Foley, Shiliang Huang, et al.
Journal of Medicinal Chemistry
|
December 21, 2012
Comparative structural and functional studies of 4-(thiazol-5-yl)-2-(phenylamino)pyrimidine-5-carbonitrile CDK9 inhibitors suggest the basis for isotype selectivity
Alison J Hole, Sonja Baumli, Hao Shao, et al.
Biorxiv : the Preprint Server for Biology
|
December 16, 2024
Systems biology-enabled targeting of NF-κΒ and BCL2 overcomes microenvironment-mediated BH3-mimetic resistance in DLBCL
Aimilia Vareli, Haripriya Vaidehi Narayanan, Heather Clark, et al.
Blood
|
July 5, 2008
Mcl-1 expression has in vitro and in vivo significance in chronic lymphocytic leukemia and is associated with other poor prognostic markers
Chris Pepper, Thet Thet Lin, Guy Pratt, et al.
Page
of 12
Search research articles
Search
Showing results (71-80 of 114) with videos related to
Sort By:
Page
of 12
Cancer
|
July 25, 2006
The effect of immunoglobulin VH gene mutation status and other prognostic factors on the incidence of major infections in patients with chronic lymphocytic leukemia
Sebastian Francis, Mamatha Karanth, Guy Pratt, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
December 18, 2008
The novel nuclear factor-kappaB inhibitor LC-1 is equipotent in poor prognostic subsets of chronic lymphocytic leukemia and shows strong synergy with fludarabine
Saman Hewamana, Thet Thet Lin, Chris Jenkins, et al.
Arrhythmia & Electrophysiology Review
|
October 28, 2022
UK Expert Consensus Statement for the Optimal Use and Clinical Utility of Leadless Pacing Systems on Behalf of the British Heart Rhythm Society
Paul R Roberts, Mohamed ElRefai, Paul Foley, et al.
Blood
|
June 12, 2010
Telomere dysfunction and fusion during the progression of chronic lymphocytic leukemia: evidence for a telomere crisis
Thet Thet Lin, Boitelo T Letsolo, Rhiannon E Jones, et al.
Oncotarget
|
February 6, 2014
A novel Cdk9 inhibitor preferentially targets tumor cells and synergizes with fludarabine
Elisabeth Walsby, Guy Pratt, Hao Shao, et al.
Communications Biology
|
July 29, 2022
DNA sequence-selective G-A cross-linking ADC payloads for use in solid tumour therapies
George Procopiou, Paul J M Jackson, Daniella di Mascio, et al.
European Journal of Medicinal Chemistry
|
February 13, 2021
Structure-based design of highly selective 2,4,5-trisubstituted pyrimidine CDK9 inhibitors as anti-cancer agents
Hao Shao, David W Foley, Shiliang Huang, et al.
Journal of Medicinal Chemistry
|
December 21, 2012
Comparative structural and functional studies of 4-(thiazol-5-yl)-2-(phenylamino)pyrimidine-5-carbonitrile CDK9 inhibitors suggest the basis for isotype selectivity
Alison J Hole, Sonja Baumli, Hao Shao, et al.
Biorxiv : the Preprint Server for Biology
|
December 16, 2024
Systems biology-enabled targeting of NF-κΒ and BCL2 overcomes microenvironment-mediated BH3-mimetic resistance in DLBCL
Aimilia Vareli, Haripriya Vaidehi Narayanan, Heather Clark, et al.
Blood
|
July 5, 2008
Mcl-1 expression has in vitro and in vivo significance in chronic lymphocytic leukemia and is associated with other poor prognostic markers
Chris Pepper, Thet Thet Lin, Guy Pratt, et al.
Page
of 12